LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/People In The News/Trelles Joins Vaters At Orthofix
People In The News

Trelles Joins Vaters At Orthofix

April 7, 2011 1 min read Premium comments

Advertisement

Trelles Joins Vaters At Orthofix
Vicente Trelles/Orthofix International

Orthofix International appointed Vicente Trelles to a newly created position titled, Senior Vice President, World Wide Operations and Shares Services on April 1.

Trelles will report directly to Bob Vaters, the company’s Chief Operating Officer. Vaters noted that he has worked with Trelles in the past and is confident his experience in providing operational leadership for global companies and his knowledge of the medical device industry “will be key as we continue executing our operational efficiency and margin expansion objectives.”

The company told OTW that Vaters worked with Trelles at Inamed Corporation from 2002 to 2006 when it was sold to Allergan. The two also co-founded the private equity group Med Opportunity Partners and worked together from 2006 until Vaters join Orthofix in 2008.

Trelles joins Orthofix with over 25 years of experience in the medical device and pharmaceutical industries. In addition to serving as partner of Med Opportunity Partners with Vaters, from 2001 to 2006, he was an Executive Vice President and Chief Operations Officer at Inamed Corporation. Prior to Inamed, Trelles held several executive positions with Allergan, Baxter Healthcare and American Hospital Supply in Europe and the United States.

Trelles has been granted an initial award of stock options to purchase 150, 000 shares of the company’s common stock at an exercise price of $33.01 per share. The company’s stock has been trading between $28 to $33 over the past three months. These options will vest in one-third annual increments beginning on the first anniversary of his date of employment.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy